يعرض 1 - 10 نتائج من 172 نتيجة بحث عن '"Dirk J. De Jong"', وقت الاستعلام: 1.42s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Gastroenterology and hepatology, Gastroenterology & Hepatology

    المصدر: Jansen, F M, Smits, L J T, Thomas, P W A, de Jong, D J, Kreijne, J E, van Dop, W A, den Broeder, N & Hoentjen, F 2023, ' Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy ', Digestive Diseases and Sciences, vol. 68, no. 7, pp. 2936-2945 . https://doi.org/10.1007/s10620-023-07950-0
    Digestive Diseases and Sciences, 68, 7, pp. 2936-2945
    Digestive Diseases and Sciences. Springer New York

    وصف الملف: application/pdf

  3. 3

    المساهمون: Gastroenterology and hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology & Hepatology

    المصدر: Lancet Gastroenterology & Hepatology, 8, 4, pp. 343-355
    Lancet Gastroenterology & Hepatology, 8, 343-355
    The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd
    LADI study group and the Dutch Initiative on Crohn and Colitis 2023, ' Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) : a pragmatic, open-label, non-inferiority, randomised controlled trial ', The Lancet Gastroenterology and Hepatology, vol. 8, no. 4, pp. 343-355 . https://doi.org/10.1016/S2468-1253(22)00434-4
    The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd.

  4. 4
  5. 5
  6. 6

    المساهمون: Gastroenterology and hepatology, AGEM - Digestive immunity, AII - Inflammatory diseases, Amsterdam Reproduction & Development (AR&D), Gastroenterology & Hepatology, Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), Translational Immunology Groningen (TRIGR), Groningen Institute for Organ Transplantation (GIOT)

    المصدر: Alimentary Pharmacology and Therapeutics, 50(4), 407-415
    Kreijne, J E, de Veer, R C, de Boer, N K, Dijkstra, G, West, R, Moorsel, S A W, de Jong, D J, van der Woude, C J, de Vries, A C & of the Dutch Initiative on Crohn, Colitis (ICC) 2019, ' Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment ', Alimentary Pharmacology and Therapeutics, vol. 50, no. 4, pp. 407-415 . https://doi.org/10.1111/apt.15402
    Alimentary Pharmacology & Therapeutics, 50, 4, pp. 407-415
    Alimentary Pharmacology & Therapeutics, 50, 407-415
    Alimentary Pharmacology & Therapeutics, 50(4), 407-415. Wiley-Blackwell Publishing Ltd
    Alimentary Pharmacology & Therapeutics, 50(4), 407-415. Wiley

    وصف الملف: application/pdf

  7. 7
  8. 8

    المصدر: Journal of Crohn's & Colitis
    Journal of Crohn's and Colitis, 15, 529-539
    Journal of Crohn's and Colitis, 15, 4, pp. 529-539
    Journal of Crohns and Colitis

    وصف الملف: application/pdf

  9. 9

    المساهمون: Gastroenterology & Hepatology, AGEM - Re-generation and cancer of the digestive system, AGEM - Digestive immunity, Gastroenterology and hepatology, Translational Immunology Groningen (TRIGR), Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), Groningen Institute for Organ Transplantation (GIOT)

    المصدر: Kreijne, J E, de Vries, A C, de Veer, R C, Bouma, G, Dijkstra, G, Voskuil, M D, West, R, van Moorsel, S A W, de Jong, D J, de Boer, N K, van der Woude, C J & the initiative on Crohn and Colitis (ICC) 2020, ' Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients ', Alimentary Pharmacology and Therapeutics, vol. 51, no. 12, pp. 1353-1364 . https://doi.org/10.1111/apt.15734
    Alimentary Pharmacology & Therapeutics, 51(12), 1353-1364. Wiley-Blackwell Publishing Ltd
    Alimentary Pharmacology & Therapeutics, 51, 12, pp. 1353-1364
    Alimentary Pharmacology and Therapeutics, 51(12), 1353-1364
    Alimentary Pharmacology & Therapeutics, 51(12), 1353-1364. Wiley
    Alimentary Pharmacology & Therapeutics, 51, 1353-1364

    وصف الملف: application/pdf

  10. 10

    المساهمون: Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), Translational Immunology Groningen (TRIGR), Groningen Institute for Organ Transplantation (GIOT), Interne Geneeskunde, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Maag Darm Lever (9), Gastroenterology and Hepatology, AGEM - Digestive immunity, Gastroenterology & Hepatology, Gastroenterology and hepatology, AII - Inflammatory diseases, Surgery

    المصدر: Biemans, V B C, van der Woude, C J, Dijkstra, G, van der Meulen-de Jong, A E, Oldenburg, B, de Boer, N K, Löwenberg, M, Srivastava, N, Bodelier, A G L, West, R L, Jansen, J M, de Vries, A C, Haans, J J L, de Jong, D J, Pierik, M J & Hoentjen, F 2020, ' Vedolizumab for Inflammatory Bowel Disease : Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry-Vedolizumab ', Clinical Pharmacology and Therapeutics, vol. 107, no. 5, pp. 1189-1199 . https://doi.org/10.1002/cpt.1712
    Clinical Pharmacology & Therapeutics, 107(5), 1189-1199. Nature Publishing Group
    Clinical Pharmacology & Therapeutics, 107(5), 1189-1199. Wiley
    Clinical pharmacology and therapeutics, 107(5), 1189-1199. Wiley-Blackwell
    Clinical Pharmacology and Therapeutics, 107(5), 1189-1199. Wiley-Blackwell
    Clinical Pharmacology and Therapeutics, 107, 1189-1199
    Clinical Pharmacology and Therapeutics
    Clinical Pharmacology and Therapeutics, 107, 5, pp. 1189-1199

    وصف الملف: application/pdf